Jiangsu Aoyang Health Industry Co Ltd operates within the Organic fibers, noncellulosic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Aoyang Health Industry Co Ltd with three other
companies in this sector in China:
Zhejiang Unifull Industrial Fiber Company Limited
sales of 5.11 billion Chinese Renmimbi [US$745.12 million]
of which 63%
was Polyester filament for industry),
Zhejiang Hailide New Material Company Limited
(3.19 billion Chinese Renmimbi [US$464.44 million]
of which 72%
was Chemical Fiber Manufacturing), and
Zhejiang Huafeng Spandex Company Limited
(4.15 billion Chinese Renmimbi [US$604.90 million]
of which 100%
During the year ended December of 2017, sales at
Jiangsu Aoyang Health Industry Co Ltd were 5.37 billion Chinese Renmimbi (US$782.27 million).
increase of 10.1%
versus 2016, when the company's sales were 4.88 billion Chinese Renmimbi.
This was the third consecutive year of growth at Jiangsu Aoyang Health Industry Co Ltd.
Sales of Health Management saw an increase
that was more than double the company's growth rate: sales were up
65.2% in 2017, from
5.24 million Chinese Renmimbi to 8.66 million Chinese Renmimbi.
Jiangsu Aoyang Health Industry Co Ltd also saw significant increases in sales in
Chemical Fiber (up 13.2% to 3.64 billion Chinese Renmimbi)